Literature DB >> 14535285

Long-term remission of Crohn's disease treated with thalidomide: a seminal case report.

S J Fishman1, N R Feins, R J D' Amato, J Folkman.   

Abstract

A 31-year-old female with severe Crohn's disease for 15 years who had been treated with corticosteroids and 6-mercaptopurine, was treated with thalidomide initially for erythema nodosum. While on thalidomide all symptoms of Crohn's disease disappeared and she was able to discontinue all other drugs. At this writing she has been on thalidomide as sole therapy for over 4 years with the exception of a 5-week hiatus, during which time her symptoms recurred, but again disappeared after resumption of thalidomide therapy. This case suggests that thalidomide may be a useful therapy for Crohn's disease and provides impetus for a clinical trial of thalidomide for Crohn's disease.

Entities:  

Year:  1999        PMID: 14535285     DOI: 10.1023/a:1009027315912

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  9 in total

1.  Differential angiogenic regulation of experimental colitis.

Authors:  John H Chidlow; Will Langston; James J M Greer; Dmitry Ostanin; Maisoun Abdelbaqi; Jeffery Houghton; Annamalai Senthilkumar; Deepti Shukla; Andrew P Mazar; Matthew B Grisham; Christopher G Kevil
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

2.  VEGF₁₆₄ isoform specific regulation of T-cell-dependent experimental colitis in mice.

Authors:  John H Chidlow; John D Glawe; Christopher B Pattillo; Sibile Pardue; Songlin Zhang; Christopher G Kevil
Journal:  Inflamm Bowel Dis       Date:  2010-11-09       Impact factor: 5.325

Review 3.  Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

Review 4.  Thalidomide in gastrointestinal disorders.

Authors:  A Bousvaros; B Mueller
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation.

Authors:  Alexandru V Olaru; Florin M Selaru; Yuriko Mori; Christine Vazquez; Stefan David; Bogdan Paun; Yulan Cheng; Zhe Jin; Jian Yang; Rachana Agarwal; John M Abraham; Themistocles Dassopoulos; Mary Harris; Theodore M Bayless; John Kwon; Noam Harpaz; Ferenc Livak; Stephen J Meltzer
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

Review 6.  Maintenance of remission in Crohn's disease: current and emerging therapeutic options.

Authors:  Matthew J Brookes; Jonathon R B Green
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease.

Authors:  J Leslie Knod; Kelly Crawford; Mary Dusing; Margaret H Collins; Artur Chernoguz; Jason S Frischer
Journal:  J Gastrointest Surg       Date:  2015-11-03       Impact factor: 3.452

8.  Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study.

Authors:  Yao He; Ren Mao; Fang Chen; Ping-Ping Xu; Bai-Li Chen; Yun Wu; Yun Qiu; Sheng-Hong Zhang; Rui Feng; Zhi-Rong Zeng; Shomron Ben-Horin; Min-Hu Chen
Journal:  Therap Adv Gastroenterol       Date:  2017-03-26       Impact factor: 4.409

9.  A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase.

Authors:  Aldo Segura-Cabrera; Reshmi Tripathi; Xiaoyi Zhang; Lin Gui; Tsui-Fen Chou; Kakajan Komurov
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.